EP2456757A4
(en )
2012-12-19
Hdac inhibitors and therapeutic methods using the same
EP2200439A4
(en )
2011-11-02
Hdac inhibitors
PL2205273T3
(en )
2017-09-29
Use of modified cells for the treatment of multiple sclerosis
HRP20181608T1
(en )
2018-12-14
Use of pde7 inhibitors for the treatment of movement disorders
IL197752A0
(en )
2009-12-24
Hdac inhibitors
ZA200801394B
(en )
2009-12-30
Novel sulphonylpyrroles as inhibitors of HDAC S novel sulphonylpyrroles
EP2049505A4
(en )
2010-12-22
Isoform-selective hdac inhibitors
EP2202228A4
(en )
2011-06-29
Amide compounds and use of the same
EP2139475A4
(en )
2012-03-07
The use of pde7 inhibitors for the treatment of movement disorders
GB0823480D0
(en )
2009-01-28
Devices for the treatment of fluids
IL213694A0
(en )
2011-07-31
Melanin production inhibitor compounds and compositions comprising the same
PL1912640T3
(en )
2015-11-30
Use of the hdac inhibitor panobinostat for the treatment of myeloma
ZA201104146B
(en )
2012-08-29
Dispersions comprising inhibitors of the hydroxyphenylpyruvate-dioxygenase
HRP20130395T1
(en )
2013-06-30
Treatment of melanoma
GB0813015D0
(en )
2008-08-20
Phosphoproteins and use of the same
ZA201100165B
(en )
2011-09-28
Use of hdac inhibitors for the treatment of hodgkin's disease
GB0624187D0
(en )
2007-01-10
HDAC inhibitors
IL201466A0
(en )
2010-05-31
Use of hdac inhibitors for the treatment of bone destruction
IL194798A0
(en )
2011-08-01
Treatment of melanoma
IL215433A0
(en )
2011-12-29
Acrylamide compounds and the use thereof
EP2144615A4
(en )
2011-02-16
Methods of use of gamma inhibitor compounds for the attenuation of pain
IL201439A0
(en )
2010-05-31
Use of hdac inhibitors for the treatment of melanoma
ZA200906906B
(en )
2010-07-28
Use of HDAC inhibitors for the treatment of melanoma
IL184620A0
(en )
2008-01-20
Composition for the treatment of inflammation
GB0809068D0
(en )
2008-06-25
The use of serine protease inhibitors